𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

✍ Scribed by Jörg Schubert; Peter Hillmen; Alexander Röth; Neal S. Young; Modupe O. Elebute; Jeffrey Szer; Giacomo Gianfaldoni; Gérard Socié; Paul Browne; Robert Geller; Russell P. Rother; Petra Muus

Book ID
108675796
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
197 KB
Volume
142
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effect of the complement inhib
Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
✍ Peter Hillmen; Modupe Elebute; Richard Kelly; Alvaro Urbano-Ispizua; Anita Hill; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract Paroxysmal nocturnal hemoglobinuria (PNH) is a debilitating and life‐threatening disease in which lysis of PNH red blood cells frequently manifests with chronic hemolysis, anemia, and thrombosis. Renal damage in PNH is associated with chronic hemosiderosis and/or microvascular thrombosi